The 2022 British guidelines for narrowband ultraviolet B phototherapy: an absolute necessity for anyone administering or prescribing phototherapy
- PMID: 35818132
- PMCID: PMC9542627
- DOI: 10.1111/bjd.21735
The 2022 British guidelines for narrowband ultraviolet B phototherapy: an absolute necessity for anyone administering or prescribing phototherapy
Abstract
Linked Article:
Comment on
-
British Association of Dermatologists and British Photodermatology Group guidelines for narrowband ultraviolet B phototherapy 2022.Br J Dermatol. 2022 Sep;187(3):295-308. doi: 10.1111/bjd.21669. Epub 2022 Jul 3. Br J Dermatol. 2022. PMID: 35604545 No abstract available.
References
-
- Goulden V, Ling TC, Babakinejad P et al. British Association of Dermatologists and British Photodermatology Group guidelines for narrowband ultraviolet B phototherapy 2022. Br J Dermatol 2022; 187:295–308. - PubMed
-
- Mohd Mustapa MF, Exton LS, Bell HK et al. Updated guidance for writing a British Association of Dermatologists clinical guideline: the adoption of the GRADE methodology 2016. Br J Dermatol 2017; 176:44–51. - PubMed
-
- Ling TC, Clayton TH, Crawley J et al. British Association of Dermatologists and British Photodermatology Group guidelines for the safe and effective use of psoralen–ultraviolet A therapy 2015. Br J Dermatol 2016; 174:24–55. - PubMed
-
- Vieyra‐Garcia PA, Wolf P. A deep dive into UV‐based phototherapy: mechanisms of action and emerging molecular targets in inflammation and cancer. Pharmacol Ther 2021; 222:107784. - PubMed
-
- Yu Z, Wolf P. How it works: the immunology underlying phototherapy. Dermatol Clin 2020; 38:37–53. - PubMed